The Italian Registry of Malnutrition in Oncology
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFondazione IRCCS Policlinico San Matteo di Pavia
About this trial
The aim of the Italian Registry of Malnutrition in Oncology (IRMO) is to set up a digital register of newly diagnosed or treated oncologic patients to monitor their nutritional status, early identify malnutrition and investigate the implications of nutritional support management. In particular, this project aims to establish a prospective cohort of cancer patients in order to investigate the effects of nutritional status and management on overall survival (OS) and progression free survival (PFS), and analyse the effects of the nutritional management and support on patients' symptoms and QoL.
Eligibility criteria
Qualifiers
Aged ≥18 years;
New diagnosis of the following cancers: head and neck, oesophagus/stomach, colorectal, hepato-biliary, pancreatic, lung, prostate, other urogenital, breast, gynaecological and, soft tissue sarcomas and melanomas; patients with a new diagnosis of metastatic disease will be also included;
Eligible for active treatment;
Written informed consent to participate in the study.
Disqualifiers
Impossibility to undertake the expected measurements;
Impossibility to guarantee the attendance of the follow-up visits.
Trial design
Treatments tested in this trial
- Cohort observational
Treatment groups
1,500 Participants
are divided into 1 treatment groupSponsors and collaborators
Fondazione IRCCS Policlinico San Matteo di Pavia
Lead sponsor
Istituto Di Ricerche Farmacologiche Mario Negri
Collaborator
Source ClinicalTrials.gov